Koru Pharma – Avalon Ultra Plus

Description

AVALON Ultra Plus is a non-surgical filler contains highly-purified hyaluronic acid (20 mg/ml) and lidocaine (0.3%) for anaesthetic effects.
It is designed to be injected into the dermis for the treatment of deep wrinkles and folds, volume restoration in cheeks, and chin augmentation.
AVALON™ Ultra Plus offers an optimal combination of viscosity and elasticity and is made from a non-animal origin stabilised hyaluronic acid. An ideal solution for the intensive filling of deep wrinkles and restoring volume with results lasting from 9 – 12 months*.

Cross-linked Hyaluronic Acid in AVALON™ Fillers

MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharma’s R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.

Indications

• Deep wrinkles and folds (Class IV-V )
• Volume loss in soft tissue
• Undefined facial contours
• Volume loss in the temporal, zygomatic and nasal areas
• Aesthetic defects in cheeks and chin areas, correction of mandibular angle

Package

1 box / 1 syringe x 1 ml + 2 needles

*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.